Cellergy Therapeutics

Recharging Life by Restoring Cellular Energy

Health Tech & Life Sciences
Active
Seed Yavne, Israel Founded 2021
Last updated 2026-06-18
Total raised
Last: 2025-09
Stage
Seed
Founded
2021
Headcount
8
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences

About

Cellergy is producing a large quantity of mitochondrial product from human primary sources for systemic, repeated administration, using fully matched allogeneic purified mitochondria delivered via IV for major systemic indications such as CNS disorders, muscle degeneration, and aging.

Its breakthrough approach harnesses the power of young, healthy mitochondria to revolutionize the treatment of degenerative and metabolic diseases. Through innovative mitochondrial transplantation therapy, Cellergy replaces compromised mitochondria with fully functional ones, effectively restoring cellular energy production and enhancing cell function.

The company is transforming human health by providing the power of young and healthy mitochondria to energize cells, fight degenerative diseases and enhance healthy longevity.

Funding history · 1 round · — total

2025-09
Undisclosed

Q&A

What is Cellergy Therapeutics' primary focus?
Cellergy Therapeutics focuses on mitochondrial transplantation therapy, aiming to treat degenerative and metabolic diseases by replacing compromised mitochondria with functional ones to restore cellular energy and enhance cell function.
When was Cellergy Therapeutics founded?
Cellergy Therapeutics was founded in May 2021.
What is Cellergy Therapeutics' current employee count?
Cellergy Therapeutics has 1-10 employees.
Which investors participated in Cellergy Therapeutics' funding round in September 2025?
In September 2025, XT Group and Fresh Fund participated in a funding round for Cellergy Therapeutics.
What is the primary sector of Cellergy Therapeutics?
Cellergy Therapeutics' primary sector is Health Tech & Life Sciences.
Where is Cellergy Therapeutics headquartered?
Cellergy Therapeutics is headquartered in Yavne, Israel.
What is Cellergy Therapeutics' current product stage?
Cellergy Therapeutics is currently in the R&D product stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B

Tags

anti-agingmetabolic-diseasediabetescell-therapycns-disordersregenerative-medicinetype-2-diabetes
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecellergy-bio.com/
LinkedInlinkedin.com/company/106252264

Identifiers & details

Founded2021-5
Employees (exact)8

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domaincellergy-bio.com

Certificate / subdomain footprint

Subdomains1